Analyst Ratings for Antares Pharma (AIS)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/1/2012 | Roth/MKM | N/A | Upgrade | Buy (N/A) |
3.50 (N/A) |
2.56 (3.30) |
28.91% | Details |
| 5/24/2011 | Oppenheimer | N/A | New Coverage | Outperform (N/A) |
N/A (N/A) |
1.70 (3.30) |
94.12% | Details |
 |
||||||||
